Using telemedicine to improve care for nursing home residents with Alzheimer's and related dementias
The Use of Telemedicine in the Care of Nursing Home Residents with Alzheimer's Disease and Related Dementias During and After the COVID-19 Pandemic
This study is looking at how using telemedicine can help nursing home residents with Alzheimer's and related dementias get better care, especially during and after the COVID-19 pandemic, by making it easier for them to see doctors without having to leave their homes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11012841 on NIH RePORTER |
What this research studies
This research investigates how telemedicine can enhance the care of nursing home residents diagnosed with Alzheimer's disease and related dementias, particularly during and after the COVID-19 pandemic. By allowing remote consultations with healthcare providers, the study aims to reduce unnecessary emergency department visits and improve access to specialized care for these residents. The project will analyze the effectiveness of telemedicine in addressing gaps in care and its impact on patient outcomes. Patients and their families may benefit from more timely and convenient access to medical expertise without the need for physical transfers.
Who could benefit from this research
Good fit: Ideal candidates for this research are nursing home residents diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are not in nursing homes or do not have a diagnosis of Alzheimer's or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and outcomes for nursing home residents with Alzheimer's and related dementias.
How similar studies have performed: Previous research has shown promising results for telemedicine in similar settings, indicating potential for success in this approach.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Barnett, Michael Lawrence — Harvard School of Public Health
- Study coordinator: Barnett, Michael Lawrence
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.